Table 4 Comparison of the preoperative general data between the two groups
Factor | Good Dispersion Group (n = 87) | Poor Distribution Group (n = 83) | t/X2 | p |
|---|---|---|---|---|
Age (\(\bar{\text{x}}\)±s, years) | 73.76 ± 8.37 | 72.39 ± 9.78 | 2.165 | 0.326 |
Gender Male/Female (n/%) | 23/64 | 21/62 | 0.029 | 0.866 |
BMI (\(\bar{\text{x}}\)±s, kg/m2) | 25.08 ± 4.91 | 24.22 ± 4.92 | 0.011 | 0.254 |
Fracture Days (\(\bar{\text{x}}\)±s, d) | 4.98 ± 1.87 | 5.04 ± 1.61 | 2.249 | 0.824 |
Menopausal Time for Female Patients (\(\bar{\text{x}}\)±s, d) | 49.18 ± 2.20 | 19.61 ± 2.77 | 1.904 | 0.313 |
Bone Density T Value (\(\bar{\text{x}}\)±s) | -3.23 ± 1.07 | -3.45 ± 0.70 | 10.401 | 0.111 |
Injured Vertebral Segments (n/%) T10 T11 T12 L1 L2 L3 L4 L5 | 9/10.3 10/11.5 14/16.1 19/21.8 6/6.9 18/20.7 10/11.5 1/1.1 | 7/8.4 5/6.0 14/16.9 18/21.7 16/19.3 14/16.9 8/9.6 1/1.2 | 7.121 | 0.416 |
Cardiovascular Disease (n/%) | 35/40.2 | 45/54.2 | 3.336 | 0.068 |
Neurological Disease (n/%) | 18/20.7 | 28/33.7 | 3.662 | 0.056 |
Respiratory System Disease (n/%) | 22/25.3 | 18/21.7 | 0.306 | 0.580 |
Endocrine System Disease (n/%) | 34/39.1 | 59/28.9 | 1.953 | 0.162 |
Metabolic Disease (n/%) | 39/44.8 | 40/48.2 | 0.193 | 0.660 |
Smoking History (n/%) | 12/13.8 | 19/22.9 | 2.358 | 0.125 |
Alcohol Consumption History (n/%) | 14/16.1 | 19/22.9 | 1.255 | 0.263 |